Etiology of Parkinson's disease

Neurology

Volumn 66, Issue 10 SUPPL. 4, 2006, Pages

  Schapira, Anthony H V ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; ANTIINFLAMMATORY AGENT; PARKIN; NERVE PROTEIN; PROTEASOME;

CELL DEATH; DJ1 GENE; ENVIRONMENTAL FACTOR; GENE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEREDITY; HUMAN; LRRK2 GENE; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PINK1 GENE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STRIATONIGRAL DEGENERATION; UCHL1 GENE; WILD TYPE; ARTICLE; BIOLOGICAL MODEL; BRAIN; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MITOCHONDRION; PATHOPHYSIOLOGY;

BRAIN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MITOCHONDRIA; MODELS, NEUROLOGICAL; NERVE TISSUE PROTEINS; PARKINSON DISEASE; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 33744982893     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.66.10_suppl_4.s10     Document Type: Review

References (138)

1. Hughes AJ Daniel SE Ben Shlomo Y Lees AJ The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service Brain 125 pt 4 2002 861 870
2. Braak H Del Tredici K Rub U de Vos RA Jansen Steur EN Braak E Staging of brain pathology related to sporadic Parkinson's disease Neurobiol Aging 24 2003 197 211
3. Hilker R Schweitzer K Coburger S Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity Arch Neurol 62 2005 378 382
4. Gowers WR Diseases of the nervous system 1888 Chapman London
5. Payami H Larsen K Bernard S Nutt J Increased risk of Parkinson's disease in parents and siblings of patients Ann Neurol 36 1994 659 661
6. Bonifati V Fabrizio E Vanacore N De Mari M Meco G Familial Parkinson's disease: a clinical genetic analysis Can J Neurol Sci 22 1995 272 279
7. Vieregge P Heberlein I Increased risk of Parkinson's disease in relatives of patients Ann Neurol 3 1995 685
8. De Michele G Filla A Volpe G Environmental and genetic risk factors in Parkinson's disease: a case-control study in southern Italy Mov Disord 11 1996 17 23
9. Marder K Tang MX Mejia H Risk of Parkinson's disease among first-degree relatives: a community-based study Neurology 47 1996 155 160
10. Gasser T Genetics of Parkinson's disease Ann Neurol 44 3 suppl 1 1998 S53 S57
11. Tanner CM Ottman R Goldman SM Parkinson disease in twins: an etiologic study JAMA 281 1999 341 346
12. Piccini P Burn DJ Ceravolo R Maraganore D Brooks DJ The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins Ann Neurol 45 1999 577 582
13. Polymeropoulos MH Lavedan C Leroy E Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
14. Kruger R Kuhn W Muller T Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease Nature Genet 18 1998 106 108
15. Singleton AB Farrer M Johnson J Alpha-synuclein locus triplication causes Parkinson's disease Science 302 2003 841
16. Farrer M Kachergus J Forno L Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications Ann Neurol 55 2004 174 179
17. Zarranz JJ Alegre J Gomez-Esteban JC The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia Ann Neurol 55 2004 164 173
18. Spillantini MG Schmidt ML Lee VM Trojanowski JQ Jakes R Goedert M Alpha-synuclein in Lewy bodies Nature 388 1997 839 840
19. Abeliovich A Schmitz Y Farinas I Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system Neuron 25 2000 239 252
20. Masliah E Rockenstein E Veinbergs I Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders Science 287 2000 1265 1269
21. Feany MB Bender WW A Drosophila model of Parkinson's disease Nature 404 2000 394 398
22. Giasson BI Duda JE Quinn SM Zhang B Trojanowski JQ Lee VM Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein Neuron 34 2002 521 533
23. Kirik D Rosenblad C Burger C Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system J Neurosci 22 2002 2780 2791
24. Conway KA Lee SJ Rochet JC Ding TT Williamson RE Lansbury PT Jr Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy Proc Natl Acad Sci USA 97 2000 571 576
25. Conway KA Rochet JC Bieganski RM Lansbury PT Jr Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct Science 294 2001 1346 1349
26. Tabrizi SJ Orth M Wilkinson JM Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity Hum Mol Genet 9 2000 2683 2689
27. Smith WW Margolis RL Li X Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells J Neurosci 25 2005 5544 5552
28. Hasegawa M Fujiwara H Nonaka T Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions J Biol Chem 277 2002 49071 49076
29. Chen L Feany MB Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease Nature Neurosci 8 2005 657 663
30. Kitada T Asakawa S Hattori N Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 392 1998 605 608
31. Yamamura Y Sobue I Ando K Iida M Yanagi T Paralysis agitans of early onset with marked diurnal fluctuation of symptoms Neurology 23 1973 239 244
32. Takahashi H Ohama E Suzuki S Familial juvenile parkinsonism: clinical and pathologic study in a family Neurology 44 3 pt 1 1994 437 441
33. Matsumine H Saito M Shimoda-Matsubayashi S Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2–27 Am J Hum Genet 60 1997 588 596
34. Hattori N Kitada T Matsumine H Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals Ann Neurol 44 1998 935 941
35. Abbas N Lucking CB Ricard S A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease Hum Mol Genet 8 1999 567 574
36. Farrer M Chan P Chen R Lewy bodies and parkinsonism in families with parkin mutations Ann Neurol 50 2001 293 300
37. West A Periquet M Lincoln S Complex relationship between Parkin mutations and Parkinson disease Am J Med Genet 114 2002 584 591
38. Shimura H Hattori N Kubo S Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase Nature Genet 25 2000 302 305
39. Zhang Y Gao J Chung KK Huang H Dawson VL Dawson TM Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1 Proc Natl Acad Sci USA 97 2000 13354 13359
40. Imai Y Soda M Inoue H Hattori N Mizuno Y Takahashi R An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin Cell 105 2001 891 902
41. Lo BC Schneider BL Bauer M Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease Proc Natl Acad Sci USA 101 2004 17510 17515
42. Goldberg MS Fleming SM Palacino JJ Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons J Biol Chem 278 2003 43628 43635
43. Palacino JJ Sagi D Goldberg MS Mitochondrial dysfunction and oxidative damage in parkin-deficient mice J Biol Chem 279 2004 18614 18622
44. Greene JC Whitworth AJ Kuo I Andrews LA Feany MB Pallanck LJ Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants Proc Natl Acad Sci USA 100 2003 4078 4083
45. Darios F Corti O Lucking CB Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death Hum Mol Genet 12 2003 517 526
46. Muftuoglu M Elibol B Dalmizrak O Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations Mov Dis 19 2004 544 548
47. Chung KK Thomas B Li X S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function Science 304 2004 1328 1331
48. Leroy E Boyer R Auburger G The ubiquitin pathway in Parkinson's disease Nature 395 1998 451 452
49. Harhangi BS Farrer MJ Lincoln S The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease Neurosci Lett 270 1999 1 4
50. Lincoln S Vaughan J Wood N Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease Neuroreport 10 1999 427 429
51. Valente EM Abou-Sleiman PM Caputo V Hereditary early-onset Parkinson's disease caused by mutations in PINK1 Science 304 2004 1158 1160
52. Unoki M Nakamura Y Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway Oncogene 20 2001 4457 4465
53. Valente EM Salvi S Ialongo T PINK1 mutations are associated with sporadic early-onset parkinsonism Ann Neurol 56 2004 336 341
54. Hatano Y Li Y Sato K Novel PINK1 mutations in early-onset parkinsonism Ann Neurol 56 2004 424 427
55. Rohe CF Montagna P Breedveld G Cortelli P Oostra BA Bonifati V Homozygous PINK1 C-terminus mutation causing early-onset parkinsonism Ann Neurol 56 2004 427 431
56. Hunter T Signaling—2000 and beyond Cell 100 2000 113 127
57. Cohen P The origins of protein phosphorylation Nature Cell Biol 4 2002 E127 E130
58. Manning G Whyte DB Martinez R Hunter T Sudarsanam S The protein kinase complement of the human genome Science 298 2002 1912 1934
59. Capaldi RA Marusich MF Taanman JW Mammalian cytochrome-c oxidase: characterization of enzyme and immunological detection of subunits in tissue extracts and whole cells Methods Enzymol 260 1995 117 132
60. Taanman JW Burton MD Marusich MF Kennaway NG Capaldi RA Subunit specific monoclonal antibodies show different steady-state levels of various cytochrome-c oxidase subunits in chronic progressive external ophthalmoplegia Biochim Biophys Acta 1315 1996 199 207
61. Schulenberg B Aggeler R Beechem JM Capaldi RA Patton WF Analysis of steady-state protein phosphorylation in mitochondria using a novel fluorescent phosphosensor dye J Biol Chem 278 2003 27251 27255
62. Chen R Fearnley IM Peak-Chew SY Walker JE The phosphorylation of subunits of complex I from bovine heart mitochondria J Biol Chem 279 2004 26036 26045
63. Murray J Marusich MF Capaldi RA Aggeler R Focused proteomics: monoclonal antibody-based isolation of the oxidative phosphorylation machinery and detection of phosphoproteins using a fluorescent phosphoprotein gel stain Electrophoresis 25 2004 2520 2525
64. Schulenberg B Goodman TN Aggeler R Capaldi RA Patton WF Characterization of dynamic and steady-state protein phosphorylation using a fluorescent phosphoprotein gel stain and mass spectrometry Electrophoresis 25 2004 2526 2532
65. Di Fonzo A Rohe CF Ferreira J A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease Lancet 365 2005 412 415
66. Nichols WC Pankratz N Hernandez D Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease Lancet 365 2005 410 412
67. Kachergus J Mata IF Hulihan M Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations Am J Hum Genet 76 2005 672 680
68. Gilks WP Abou-Sleiman PM Gandhi S A common LRRK2 mutation in idiopathic Parkinson's disease Lancet 365 2005 415 416
69. Deng H Le W Guo Y Hunter CB Xie W Jankovic J Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation Ann Neurol 57 2005 933 934
70. Zabetian CP Samii A Mosley AD A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations Neurology 65 2005 741 744
71. Hernandez D Paisan RC Crawley A The dardarin G 2019 S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases Neurosci Lett 389 2005 137 139
72. Toft M Sando SB Melquist S LRRK2 mutations are not common in Alzheimer's disease Mech Ageing Dev 126 2005 1201 1205
73. Kay DM Kramer P Higgins D Zabetian CP Payami H Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation Mov Disord 20 2005 1077 1078
74. Adams JR van Netten H Schulzer M PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation Brain 128 pt 12 2005 2777 2785
75. Funayama M Hasegawa K Kowa H Saito M Tsuji S Obata F A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1 Ann Neurol 51 2002 296 301
76. Wszolek ZK Pfeiffer RF Tsuboi Y Autosomal dominant parkinsonism associated with variable synuclein and tau pathology Neurology 62 2004 1619 1622
77. Zimprich A Biskup S Leitner P Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology Neuron 44 2004 601 607
78. Ross OA Farrer MJ Pathophysiology, pleiotrophy and paradigm shifts: genetic lessons from Parkinson's disease Biochem Soc Trans 33 pt 4 2005 586 590
79. Ridley AJ Rho family proteins: coordinating cell responses Trends Cell Biol 11 2001 471 477
80. Scott WK Nance MA Watts RL Complete genomic screen in Parkinson disease: evidence for multiple genes JAMA 286 2001 2239 2244
81. DeStefano AL Golbe LI Mark MH Genome-wide scan for Parkinson's disease: the GenePD Study Neurology 57 2001 1124 1126
82. Farrer M Maraganore DM Lockhart P alpha-Synuclein gene haplotypes are associated with Parkinson's disease Hum Mol Genet 10 2001 1847 1851
83. Tan EK Tan C Shen H Alpha synuclein promoter and risk of Parkinson's disease: microsatellite and allelic size variability Neurosci Lett 336 2003 70 72
84. West AB Maraganore D Crook J Functional association of the parkin gene promoter with idiopathic Parkinson's disease Hum Mol Genet 11 2002 2787 2792
85. Hicks AA Petursson H Jonsson T A susceptibility gene for late-onset idiopathic Parkinson's disease Ann Neurol 52 2002 549 555
86. Rajput AH Uitti RJ Stern W Laverty W Early onset Parkinson's disease in Saskatchewan—environmental considerations for etiology Can J Neurol Sci 13 1986 312 316
87. Rajput AH Uitti RJ Rajput AH Neurological disorders and services in Saskatchewan—a report based on provincial health care records Neuroepidemiology 7 1988 145 151
88. Behari M Srivastava Ak Das RR Pandey RM Risk factors for Parkinson's disease I In Indian patients J Neurol Sci 190 2001 49 55
89. Semchuk KM Love EJ Lee RG Parkinson's disease and exposure to rural environmental factors: a population based case-control study Can J Neurol Sci 18 1991 279 286
90. Barbeau A Roy M Bernier G Campanella G Paris S Ecogenetics of Parkinson's disease: prevalence and environmental aspects in rural areas Can J Neurol Sci 14 1987 36 41
91. Gorrell JM DiMonte D Graham D The role of the environment in Parkinson's disease Environ Health Perspect 104 1996 652 654
92. Fall PA Fredrikson M Axelson O Granerus AK Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden Mov Disord 14 1999 28 37
93. Semchuk KM Love EJ Lee RG Parkinson's disease and exposure to agricultural work and pesticide chemicals Neurology 42 1992 1328 1335
94. Seidler A Hellenbrand W Robra BP Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany Neurology 46 1996 1275 1284
95. Fleming L Mann JB Bean J Briggle T Sanchez-Ramos JR Parkinson's disease and brain levels of organochlorine pesticides Ann Neurol 36 1994 100 103
96. Corsini GU Pintus S Chiueh CC Weiss JF Kopin IJ 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate Eur J Pharmacol 119 1985 127 128
97. Tanner CM Goldman SM Epidemiology of Parkinson's disease Neurol Clin 14 1996 317 335
98. Elwan MA Richardson JR Guillot TS Caudle WM Miller GW Pyrethroid pesticide-induced alterations in dopamine transporter function Toxicol Appl Pharmacol 211 2006 188 197
99. Pittman JT Dodd CA Klein BG Immunohistochemical changes in the mouse striatum induced by the pyrethroid insecticide permethrin Int J Toxicol 22 2003 359 370
100. Bloomquist JR Barlow RL Gillette JS Li W Kirby ML Selective effects of insecticides on nigrostriatal dopaminergic nerve pathways Neurotoxicology 23 2002 537 544
101. Imamura L Yasuda M Kuramitsu K Hara D Tabuchi A Tsuda M Deltamethrin, a pyrethroid insecticide, is a potent inducer for the activity-dependent gene expression of BDNF in neurons J Pharmacol Exp Ther 316 2006 136 143
102. Betarbet R Sherer TB MacKenzie G Garcia-Osuna M Panov AV Greenamyre JT Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nature Neurosci 3 2000 1301 1306
103. Manning-Bog AB McCormack AL Li J Uversky VN Fink AL Di Monte DA The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein J Biol Chem 277 2002 1641 1644
104. Champy P Hoglinger GU Feger J Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe J Neurochem 88 2004 63 69
105. Tipton KF Singer TP Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds J Neurochem 61 1993 1191 1206
106. Huang CC Lu CS Chu NS Progression after chronic manganese exposure Neurology 43 1993 1479 1483
107. Mena I Manganese poisoning Vinken PJ Bruyn GW Handbook of clinical neurology. Vol 36. Intoxications of the nervous system. Part I 1979 North Holland Publishing Amsterdam 217 237
108. Jankovic J Searching for a relationship between manganese and welding and Parkinson's disease Neurology 64 2005 2021 2028
109. Baron JA Cigarette smoking and Parkinson's disease Neurology 36 1986 1490 1496
110. Ascherio A Zhang SM Hernan MA Prospective study of caffeine consumption and risk of Parkinson's disease in men and women Ann Neurol 50 2001 56 63
111. McGeer PL Itagaki S Boyes BE McGeer EG Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains Neurology 38 1988 1285 1291
112. Boka G Anglade P Wallach D Javoy-Agid F Agid Y Hirsch EC Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease Neurosci Lett 172 1994 151 154
113. Hunot S Dugas N Faucheux B FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells J Neurosci 19 1999 3440 3447
114. McGeer PL Schulzer M McGeer EG Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies Neurology 47 1996 425 432
115. in t’ Veld BA Ruitenberg A Hofman A Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease N Engl J Med 345 2001 1515 1521
116. Chen H Zhang SM Hernan MA Schwarzschild MA Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease Arch Neurol 60 2003 1059 1064
117. Schapira AHV Cooper JM Dexter D Mitochondrial complex I deficiency in Parkinson's disease Ann Neurol 26 1989 122 123
118. Schapira AH Cooper JM Dexter D Jenner P Clark JB Marsden CD Mitochondrial complex I deficiency in Parkinson's disease Lancet 1 1989 1269
119. Mann VM Cooper JM Daniel SE Complex I, iron, and ferritin in Parkinson's disease substantia nigra Ann Neurol 36 1994 876 881
120. Schapira AH Mann VM Cooper JM Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease J Neurochem 55 1990 2142 2145
121. Schapira AH Evidence for mitochondrial dysfunction in Parkinson's disease—a critical appraisal Mov Disord 9 1994 125 138
122. Taylor DJ Krige D Barnes PR A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease J Neurol Sci 125 1994 77 81
123. Penn AM Roberts T Hodder J Allen PS Zhu G Martin WR Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle Neurology 45 1995 2097 2099
124. Parker WD Jr Boyson SJ Parks JK Abnormalities of the electron transport chain in idiopathic Parkinson's disease Ann Neurol 26 1989 719 723
125. Krige D Carroll MT Cooper JM Marsden CD Schapira AH Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group Ann Neurol 32 1992 782 788
126. Haas RH Nasirian F Nakano K Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease Ann Neurol 37 1995 714 722
127. Wooten GF Currie LJ Bennett JP Harrison MB Trugman JM Parker WD Jr Maternal inheritance in Parkinson's disease Ann Neurol 41 1997 265 268
128. Schapira AH Holt IJ Sweeney M Mitochondrial DNA analysis in Parkinson's disease Mov Disord 5 1990 294 297
129. Ozawa T Tanaka M Ino H Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease Biochem Biophys Res Commun 176 1991 938 946
130. Ikebe S Tanaka M Ozawa T Point mutations of mitochondrial genome in Parkinson's disease Brain Res Mol Brain Res 28 1995 281 295
131. Shoffner JM Brown MD Torroni A Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients Genomics 17 1993 171 184
132. Lucking CB Kosel S Mehraein P Graeber MB Absence of the mitochondrial A7237T mutation in Parkinson's disease Biochem Biophys Res Commun 211 1995 700 704
133. Kosel S Grasbon-Frodl EM Hagenah JM Graeber MB Vieregge P Parkinson disease: analysis of mitochondrial DNA in monozygotic twins Neurogenetics 2 2000 227 230
134. Richter G Sonnenschein A Grunewald T Reichmann H Janetzky B Novel mitochondrial DNA mutations in Parkinson's disease J Neural Transm 109 2002 721 729
135. Vives-Bauza C Andreu AL Manfredi G Sequence analysis of the entire mitochondrial genome in Parkinson's disease Biochem Biophys Res Commun 290 2002 1593 1601
136. van der Walt JM Nicodemus KK Martin ER Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease Am J Hum Genet 72 2003 804 811
137. Pyle A Foltynie T Tiangyou W Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD Ann Neurol 57 2005 564 567
138. Ross OA McCormack R Maxwell LD mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson's disease in the Irish Exp Gerontol 38 2003 397 405